Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study.

MLA

Takeuchi, Tsutomu, et al. “Upadacitinib Monotherapy versus Methotrexate Monotherapy in Methotrexate-Naïve Japanese Patients with Rheumatoid Arthritis: A Sub-Analysis of the Phase 3 SELECT-EARLY Study.” Modern Rheumatology, vol. 31, no. 3, May 2021, pp. 534–42. EBSCOhost, https://doi.org/10.1080/14397595.2020.1847776.

APA

Takeuchi, T., Rischmueller, M., Blanco, R., Xavier, R. M., Ueki, Y., Atsumi, T., Chen, S., Friedman, A., Pangan, A. L., Strand, V., & van Vollenhoven, R. F. (2021). Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study. Modern Rheumatology, 31(3), 534–542. https://doi.org/10.1080/14397595.2020.1847776

Chicago

Takeuchi, Tsutomu, Maureen Rischmueller, Ricardo Blanco, Ricardo M Xavier, Yukitaka Ueki, Tatsuya Atsumi, Su Chen, et al. 2021. “Upadacitinib Monotherapy versus Methotrexate Monotherapy in Methotrexate-Naïve Japanese Patients with Rheumatoid Arthritis: A Sub-Analysis of the Phase 3 SELECT-EARLY Study.” Modern Rheumatology 31 (3): 534–42. doi:10.1080/14397595.2020.1847776.